European Journal of Biomedical and Pharmaceutical Sciences

A CLINICAL EVALUATION OF HEMAKANDA GHRUTA ON GARBHASHAYA ARBUDA (UTERINE FIBROID)

Dr. Yogesh L. Manani* and Prof. L. P. Dei

ABSTRACT

In India, the prevalence of uterine fibroids (fibromyoma/leomyoma) among women hovers between 30-50%. Special reference of Arbuda of female reproductive system is not available in any classics but it can be called as Garbhashaya Arbuda on the basis of its origin from Garbhashaya and its surroundings and can be correlated with uterine fibroid. It is the need of the era that, a secure, less expensive more effective therapy for this sensitive problem should be developed. Patients of reproductive or perimenopausal age with having complaint of menstrual abnormality, dysmenorrhoea, dyspareunia, pressure symptoms, lower abdominal or pelvic pain, abdominal enlargement, infertility etc., investigated with the help of Ultrasonography for confirmation were selected. Total 16 patients were registered, out of them 15 patients completed the course of treatment. Hemakanda Ghruta(5 ml) was given orally before meal for 3months (with Anupana of Kanchanara Twak Kashaya). The drug had shown significant result on symptoms like, Menorrhagia, dysmenorrhoea, irregular menses and lower abdominal pain. From the above study it has concluded that the drug Hemakanda Ghrutais effective to manage symptoms of Garbhashaya Arbuda (Uterine fibroid) with no apparent evidence of complication.

Keywords: Garbhashaya Arbuda, Hemakanda Ghruta, Uterine fibroid.